Factors associated with lack of response to valproic acid monotherapy in juvenile myoclonic epilepsy

被引:17
|
作者
Jayalakshmi, Sita [1 ]
Vooturi, Sudhindra [1 ]
Bana, Ashok Kumar [2 ]
Sailaja, Sarva [2 ]
Somayajula, Shanmukhi [1 ]
Mohandas, Surath [1 ]
机构
[1] Krishna Inst Med Sci, Dept Neurol, Hyderabad, Andhra Pradesh, India
[2] Nizams Inst Med Sci, Dept Neurol, Hyderabad, Andhra Pradesh, India
来源
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY | 2014年 / 23卷 / 07期
关键词
Lack of response to valproic acid; Focal EEG abnormality; Juvenile myoclonic epilepsy; Psychiatric disorder; LONG-TERM; FEATURES; TOPIRAMATE; PROGNOSIS;
D O I
10.1016/j.seizure.2014.03.017
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Purpose: To determine factors associated with lack of response to valproic acid (VPA) in juvenile myoclonic epilepsy (JME). Method: Retrospective analysis of clinical and EEG data of 201 patients with JME who had at least 3 years follow up was performed. Psychiatric evaluation was performed using ICD-10 by structured clinical interview. Patients were divided into two groups: VPA responders (seizure free for 2 or more years) and those with lack of response to VPA. Effect size for non-response and correlations for variables significantly different between the groups was performed, the findings were confirmed by ROC curves. Results: The mean duration of follow up was 7.75 (range 3-12) years; 55.2% were males. Focal semiologic features were noted is 16%. EEG was abnormal in 67%; focal EEG abnormalities were noted in 32.8%. Coexisting psychiatric disorders (PDs) were found in 33.3%. Lack of response to VPA was noted in 19%. Diagnosis of PDs and focal EEG abnormalities significantly increased the risk of VPA non-responsiveness by 5.54 (95% CI of 2.60-11.80; p <0.0001) and 3.01 times respectively (95% Cl of 1.40-6.47; p <0.008). Diagnosis of PDs showed significant correlation (r = 0.332; p <0.0001) and association (AUC 0.700; p < 0.0001) with lack of response to VPA. Though focal EEG abnormalities increased the chances, it did not correlate with lack of response to VPA. Conclusion: Lack of response to VPA was noted 19% of patients with JME. Coexisting PDs showed significant correlation and association with lack of response to VPA. (C) 2014 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:527 / 532
页数:6
相关论文
共 50 条
  • [21] A single dose of 500 mg/d of valproic acid can be effective in Juvenile Myoclonic Epilepsy
    DeToffol, B
    Autret, A
    REVUE NEUROLOGIQUE, 1996, 152 (11) : 708 - 710
  • [22] Chronodependency and provocative factors in juvenile myoclonic epilepsy
    Trenite, Dorothee G. A. Kasteleijn-Nolst
    de Weerd, Al
    Beniczky, Sandor
    EPILEPSY & BEHAVIOR, 2013, 28 : S25 - S29
  • [23] Valproic Acid-Induced Pancreatitis in a 15-Year-Old Boy With Juvenile Myoclonic Epilepsy
    Veri, Kadi
    Uibo, Oivi
    Talvik, Inga
    Talvik, Tiina
    MEDICINA-LITHUANIA, 2013, 49 (11): : 487 - 489
  • [24] Cognitive decline and speech disorders in adolescents with juvenile myoclonic epilepsy treated by valproic acid (a clinical case)
    Gamirova, R.
    Gorobets, E.
    Esin, R.
    Akhutina, T.
    Gamirova, R.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2021, 51 : 173 - 174
  • [25] Levetiracetam monotherapy in the treatment of convulsive seizures in patients with juvenile myoclonic epilepsy
    Resor, SR
    Resor, LR
    NEUROLOGY, 2002, 58 (07) : A294 - A294
  • [26] Valproate as monotherapy for juvenile myoclonic epilepsy: Dose-effect study
    Sundqvist, A
    Tomson, T
    Lundkvist, B
    THERAPEUTIC DRUG MONITORING, 1998, 20 (02) : 149 - 157
  • [27] Provocative factors and treatment response in juvenile myoclonic epilepsy - experience from a tertiary epilepsy center
    Mulhan, K.
    Tekin, B.
    Erdogan, M.
    Sari, H.
    Daryan, M. D.
    Atakli, D.
    CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2020, 83 (02) : 180 - +
  • [28] Clinical and psychosocial factors associated with seizure control in patients with juvenile myoclonic epilepsy
    Sanchez-Zapata, Paola
    Zapata-Berruecos, Jose F.
    REVISTA DE NEUROLOGIA, 2019, 69 (11) : 453 - 460
  • [29] ABCC2 rs2273697 is associated with valproic acid concentrations in patients with epilepsy on valproic acid monotherapy
    Chen, Juan
    Su, Qi-Biao
    Tao, Yu-Qian
    Qin, Jia-Ming
    Zhou, Yi
    Zhou, Shan
    Li, Hong-Liang
    Chen, Zhuo-Jia
    Zhou, Ya-Fang
    Zhou, Lie-Min
    Wang, Xue-Ding
    Huang, Min
    PHARMAZIE, 2018, 73 (05): : 279 - 282
  • [30] Genetic polymorphisms and valproic acid plasma concentration in children with epilepsy on valproic acid monotherapy
    Mei, Shenghui
    Feng, Weixing
    Zhu, Leting
    Yu, Yazhen
    Yang, Weili
    Gao, Baoqin
    Wu, Xiaojuan
    Zhao, Zhigang
    Fang, Fang
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2017, 51 : 22 - 26